Walleye Trading
DCPH

Walleye Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Walleye Trading’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,400
Closed -$22K – 5809
2022
Q1 		$22K Buy
+2,400
New +$20.4K ﹤0.01% 4746
2021
Q3 		– Sell
-5,300
Closed -$194K – 5839
2021
Q2 		$194K Buy
5,300
+2,500
+89% +$96.8K ﹤0.01% 3960
2021
Q1 		$126K Sell
2,800
-8,300
-75% -$386K ﹤0.01% 3971
2020
Q4 		$633K Buy
+11,100
New +$658K ﹤0.01% 2445
2020
Q3 		– Sell
-6,400
Closed -$382K – 4731
2020
Q2 		$382K Buy
+6,400
New +$342K ﹤0.01% 2505

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Walleye Trading's DCPH Position: Q1 2024 in Review

Walleye Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 14,269 shares — an estimated $230K sold.

Walleye Trading first reported a position in DCPH in Q3 2020 and held it in 4 quarters. The position peaked at $627K in Q3 2020. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • Walleye Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 14,269 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $230K.
  • Walleye Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Walleye Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $627K in Q3 2020.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.